TABLE 1.
No. of macaques | Group | Prime (wk 0, oral + intranasal; wk 12, intratracheal) | Boost (wk 24, intramuscular; wk 36, intramuscular) |
---|---|---|---|
8 | I | Ad5hr-SIV env/rev | SIV gp120 in MPL-SE (100 μg) |
7 | II | Ad5hr-SIV env/rev + Ad5hr-SIV gag | SIV gp120 in MPL-SE (100 μg) |
8 | III | Ad5hr-SIV env/rev + Ad5hr-SIV nef | SIV gp120 in MPL-SE (100 μg) |
8 | IV | Ad5hr-SIV env/rev + Ad5hr-SIV gag + Ad5hr-SIV nef | SIV gp120 in MPL-SE (100 μg) |
8 | V | Ad5hr-SIV env/rev | SIV peptomer in PBS (100 μg) |
8 | VI | Ad5hr vector | MPL-SE |
The intrarectal challenge at week 42 for all immunization groups was SIVmac251 at a 1:10 dilution in PBS.